Kansara, P., Weiss, S., Weintraub, W. S., Hann, M. C., Tcheng, J., Rab, S. T., … Interventional Council of the American College of Cardiology, . (2015). Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG? Jacc Cardiovasc Interv, 8(13), 1647–1656. https://doi.org/10.1016/j.jcin.2015.07.020

Kansara, Pranav, Sandra Weiss, William S. Weintraub, Matthew C. Hann, James Tcheng, S Tanveer Rab, Lloyd W. Klein, and Lloyd W. Interventional Council of the American College of Cardiology. “Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?” Jacc Cardiovasc Interv 8, no. 13 (November 2015): 1647–56. https://doi.org/10.1016/j.jcin.2015.07.020.

Kansara P, Weiss S, Weintraub WS, Hann MC, Tcheng J, Rab ST, et al. Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG? Jacc Cardiovasc Interv. 2015 Nov;8(13):1647–56.

Kansara, Pranav, et al. “Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?” Jacc Cardiovasc Interv, vol. 8, no. 13, Nov. 2015, pp. 1647–56. Pubmed, doi:10.1016/j.jcin.2015.07.020.

Kansara P, Weiss S, Weintraub WS, Hann MC, Tcheng J, Rab ST, Klein LW, Interventional Council of the American College of Cardiology. Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG? Jacc Cardiovasc Interv. 2015 Nov;8(13):1647–1656.